Share


Hi , 


This week, SynBioBeta 2025 is calling all innovators to the front lines of biotech storytelling. Got a big announcement? Don’t miss your chance to capture the spotlight in front of top-tier media outlets like The Economist, Forbes, Wired, and more—press releases are due by April 1. Meanwhile, digital poster sessions by Academic Row are opening up exclusive opportunities to share your research with a global network of investors and researchers, with abstract submissions closing on March 17. In the news this week, the future of biotech unfolds through a captivating mix of breakthrough insights and hard-hitting news. An insightful commentary reveals how post-Chevron regulatory shifts may finally clear the way for next-gen innovation while next-generation ALA-CART therapies promise to deliver made-to-order cancer cures. In agriculture, AI-powered platforms are revolutionizing crop breeding, and researchers are uncovering that cartilage grown from nasal cells could redefine knee repair!





Enjoy your week and buy your Conference Ticket today!




Got a big announcement for SynBioBeta 2025? Don't miss the chance to get in front of top journalists from The Economist, Forbes, The New Yorker, Wired, STAT, GEN, Genome Web, and more. Press releases are due by 4/1! Upload your materials now or send them directly to Katie Orrell.



Our Digital Poster Sessions at The Global Synthetic Biology Conference offer a unique and valuable opportunity to showcase your work to a global community of researchers, entrepreneurs, and investors in synthetic biology. This year, you'll find them conveniently located by the Academic Row in the Exhibit Hall. The abstract submission deadline is March 17th, so don’t miss your chance to participate!


Click Here to learn more!

Check Out Our Latest Sponsors and Exhibitors for SynBioBeta 2025!


Interested in Sponsoring or Exhibiting? Click here for more information, or contact Anissa Cooke

Biocom California's second annual Converge Summit is an executive-level conference dedicated to advancing human health through the collaboration of life science and technology. This summit will feature some of the pioneers of this convergence from the Chan Zuckerberg Initiative, General Catalyst, Genesis Therapeutics, and Microsoft while bringing together the brightest minds in both sectors to exchange ideas, break down barriers, strengthen relationships, and spark world-changing innovation. Apply Now to secure your place at this can't-miss event.

Courts, Congress, and Confusion: Biotechnology Regulation Post-Chevron  

Chevron's fall leaves biotech stakeholders navigating uncertainty but opens avenues for clearer, more collaborative regulation.


ALA-CART: Serving Up a Made-to-Order Cancer Cure

Researchers have developed a next-generation CAR-T therapy designed to overcome cancer cell resistance and improve patient outcomes.



Verinomics Unveils AI-Powered Platforms to Revolutionize Crop Breeding

The Genesis™ and Genova™ platforms are unlocking faster, more precise crop improvement without relying on transgenic modifications.


Following Your Nose Could Be the Key to Cartilage Repair

Scientists have discovered that cartilage grown from nasal cells significantly outperforms traditional grafts in repairing knee injuries.



How AI Wearables are Giving Blood Pressure Cuffs the Squeeze

A new theoretical framework from KAIST could make cuffless blood pressure sensors medically viable.


Like our Digest?

Please feel free to share with friends,

family, and co-workers!


SynBioBeta, LLC

3559 Mount Diablo Boulevard #2, Lafayette, CA 94549

info@synbiobeta.com


Sent to: _t.e.s.t_@example.com

Unsubscribe

SynBioBeta, 3559 Mount Diablo Boulevard #2, Lafayette, CA 94549, United States


Email Marketing by ActiveCampaign